Editorial: Ocular fibrosis: molecular and cellular mechanisms and treatment modalities
Front Ophthalmol (Lausanne)
.
2024 Jan 25:4:1362601.
doi: 10.3389/fopht.2024.1362601.
eCollection 2024.
Authors
Christine M Sorenson
1
2
,
Teri L Belecky-Adams
3
,
Nader Sheibani
2
4
Affiliations
1
Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States.
2
McPherson Eye Research Institute, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States.
3
Department of Biology, Indiana University-Indianapolis, Indianapolis, IN, United States.
4
Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States.
PMID:
38984111
PMCID:
PMC11182198
DOI:
10.3389/fopht.2024.1362601
No abstract available
Keywords:
extracellular matrix; inflammation; integrins; microRNA; myofibroblasts; ocular fibrosis.
Publication types
Editorial
Grants and funding
P30 EY016665/EY/NEI NIH HHS/United States
R01 EY030076/EY/NEI NIH HHS/United States
R15 EY033968/EY/NEI NIH HHS/United States